Reaction
Escherichia Test Positive reporting signals
As of the last recalculation, Escherichia Test Positive appears in 1,185 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is PEGASPARGASE (PRR 62.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pegaspargase | 42 | 62.4 | 62.6 |
| Vincristine Sulfate | 63 | 39.8 | 39.9 |
| Cytarabine | 75 | 23.3 | 23.4 |
| Chlorhexidine Gluconate | 12 | 23.3 | 23.3 |
| Mercaptopurine | 21 | 21.6 | 21.7 |
| Busulfan | 19 | 21.5 | 21.6 |
| Ampicillin | 10 | 21.4 | 21.4 |
| Ampicillin Sodium | 10 | 21.4 | 21.4 |
| Trimethoprim | 12 | 18.1 | 18.1 |
| Alemtuzumab | 19 | 17.5 | 17.5 |
| Brentuximab Vedotin | 10 | 17.3 | 17.3 |
| Sirolimus | 13 | 17.1 | 17.1 |
| Norepinephrine Bitartrate | 11 | 13.5 | 13.5 |
| Doxorubicin Hydrochloride | 24 | 13.2 | 13.2 |
| Norepinephrine | 7 | 11.6 | 11.6 |
| Leucovorin Calcium | 12 | 11.1 | 11.1 |
| Baricitinib | 6 | 11.0 | 11.0 |
| Posaconazole | 10 | 10.9 | 10.9 |
| Micafungin Sodium | 5 | 10.4 | 10.4 |
| Cefepime Hydrochloride | 9 | 9.9 | 9.9 |
| Azacitidine For | 10 | 9.7 | 9.7 |
| Posaconazole Delayed-Release | 6 | 9.6 | 9.6 |
| Ifosfamide | 11 | 9.1 | 9.1 |
| Eculizumab | 27 | 8.9 | 8.9 |
| Etoposide | 33 | 8.1 | 8.1 |
| Pertuzumab | 12 | 7.8 | 7.8 |
| Azacitidine | 13 | 7.8 | 7.8 |
| Axicabtagene Ciloleucel | 4 | 7.1 | 7.1 |
| Cisplatin | 31 | 7.1 | 7.1 |
| Blinatumomab | 4 | 6.8 | 6.8 |
| Dalfampridine | 25 | 6.2 | 6.2 |
| Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 3 | 6.0 | 6.0 |